USE OF METHOTREXATE AND 5-FU FOR RECURRENT HEAD AND NECK-CANCER

被引:0
|
作者
JACOBS, C [1 ]
机构
[1] STANFORD UNIV,MED CTR,SCH MED,DEPT MED,DIV ONCOL,STANFORD,CA 94305
来源
CANCER TREATMENT REPORTS | 1982年 / 66卷 / 11期
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1925 / 1928
页数:4
相关论文
共 50 条
  • [1] PHASE-I-II TRIAL WITH CISPLATIN AND 5-FU IN RECURRENT HEAD AND NECK-CANCER - AN EFFECTIVE OUTPATIENT SCHEDULE
    MERLANO, M
    TATAREK, R
    GRIMALDI, A
    MARGARINO, G
    ROSSO, R
    CANCER TREATMENT REPORTS, 1985, 69 (09): : 961 - 964
  • [2] CLINICAL PHARMACOKINETIC STUDY OF 5-FU IN CONTINUOUS 5-DAY INFUSIONS FOR HEAD AND NECK-CANCER
    THYSS, A
    MILANO, G
    RENEE, N
    VALLICIONI, J
    SCHNEIDER, M
    DEMARD, F
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1986, 16 (01) : 64 - 66
  • [3] ACTIVITY OF 96 HOUR TO 120 HOUR 5-FLUOROURACIL (5-FU) INFUSION IN ADVANCED AND RECURRENT HEAD AND NECK-CANCER (HNC)
    KISH, J
    TAPAZOGLOU, E
    ENSLEY, J
    ALSARRAF, M
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1985, 26 (MAR): : 168 - 168
  • [4] IMPROVED CONTROL IN ADVANCED HEAD AND NECK-CANCER WITH SIMULTANEOUS RADIATION AND CISPLATIN/5-FU CHEMOTHERAPY
    TAYLOR, SG
    MURTHY, AK
    SHOWEL, JL
    CALDARELLI, DD
    HUTCHINSON, JC
    HOLINGER, LD
    KRAMER, T
    KIEL, K
    CANCER TREATMENT REPORTS, 1985, 69 (09): : 933 - 939
  • [5] METHOTREXATE AND 5-FLUOROURACIL IN HEAD AND NECK-CANCER
    RINGBORG, U
    EWERT, G
    KINNMAN, J
    LUNDQUIST, PG
    STRANDER, H
    SEMINARS IN ONCOLOGY, 1983, 10 (02) : 20 - 22
  • [6] ALTERNATION OF CHEMOTHERAPY (CISPLATIN AND 5-FU) AND RADIOTHERAPY IN THE MANAGEMENT OF ADVANCED OR RECURRENT HEAD AND NECK-CANCER - A PHASE-II STUDY
    GRIMALDI, A
    MERLANO, M
    BENASSO, M
    MARGARINO, G
    SCASSO, F
    CORVO, R
    ROSSO, R
    CHEMIOTERAPIA, 1986, 5 (05): : 356 - 359
  • [7] THE EFFECT OF SEQUENTIAL METHOTREXATE AND 5-FLUOROURACIL IN PATIENTS WITH RECURRENT HEAD AND NECK-CANCER
    LINDELOV, B
    HANSEN, HS
    ACTA ONCOLOGICA, 1989, 28 (02) : 227 - 230
  • [8] 5-FU THERAPEUTIC MONITORING WITH DOSE ADJUSTMENT LEADS TO AN IMPROVED THERAPEUTIC INDEX IN HEAD AND NECK-CANCER
    SANTINI, J
    MILANO, G
    THYSS, A
    RENEE, N
    VIENS, P
    AYELA, P
    SCHNEIDER, M
    DEMARD, F
    BRITISH JOURNAL OF CANCER, 1989, 59 (02) : 287 - 290
  • [9] Oral 5-FU alternatives for the treatment of head and neck cancer
    Vokes, EE
    Brockstein, BE
    Humerickhouse, R
    Haraf, DJ
    ONCOLOGY-NEW YORK, 1998, 12 (10): : 35 - 38
  • [10] EVALUATION OF HIGH-DOSE CISPLATIN AND 5-FU INFUSION AS INITIAL THERAPY IN ADVANCED HEAD AND NECK-CANCER
    KISH, JA
    ENSLEY, JF
    JACOBS, JR
    BINNS, P
    ALSARRAF, M
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1988, 11 (05): : 553 - 557